BackNovo Nordisk A/S Class B Overview

Novo Nordisk A/S Class B Intangible Assets

Novo Nordisk A/S Class B's intangible assets is $110B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$110.03B

Peer average

Loading

Novo Nordisk A/S Class B Intangible Assets History

Loading

Novo Nordisk A/S Class B vs. peers: Intangible Assets Comparison

Loading

Novo Nordisk A/S Class B Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Novo Nordisk A/S Class B (NONOF) FAQ

The latest intangible assets for NONOF is $110B as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Novo Nordisk A/S Class B's historical trend and sector peers before judging valuation or financial health.

Over the past year, NONOF's intangible assets moved from $0 to $110B. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Novo Nordisk A/S Class B's operating scale or balance-sheet position.

A intangible assets figure of $110B for NONOF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NONOF's intangible assets ($110B), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Novo Nordisk A/S Class B's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.